Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Short-term Investments (2021 - 2025)

Historic Short-term Investments for InspireMD (NSPR) over the last 7 years, with Q2 2025 value amounting to $7.9 million.

  • InspireMD's Short-term Investments fell 5811.59% to $7.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $7.9 million, marking a year-over-year decrease of 5811.59%. This contributed to the annual value of $15.7 million for FY2024, which is 4649.63% down from last year.
  • As of Q2 2025, InspireMD's Short-term Investments stood at $7.9 million, which was down 5811.59% from $13.7 million recorded in Q1 2025.
  • InspireMD's 5-year Short-term Investments high stood at $29.4 million for Q4 2023, and its period low was $7.9 million during Q2 2025.
  • Its 5-year average for Short-term Investments is $20.0 million, with a median of $21.1 million in 2021.
  • Per our database at Business Quant, InspireMD's Short-term Investments crashed by 6074.46% in 2023 and then surged by 18371.26% in 2024.
  • Quarter analysis of 5 years shows InspireMD's Short-term Investments stood at $22.0 million in 2021, then plummeted by 40.23% to $13.2 million in 2022, then skyrocketed by 123.09% to $29.4 million in 2023, then tumbled by 46.5% to $15.7 million in 2024, then crashed by 49.97% to $7.9 million in 2025.
  • Its Short-term Investments stands at $7.9 million for Q2 2025, versus $13.7 million for Q1 2025 and $15.7 million for Q4 2024.